Finder makes money from featured partners, but editorial opinions are our own.

How to buy Insulet Corporation (PODD) stocks in Canada

Learn how to easily invest in Insulet Corporation stocks.

Insulet Corporation is a medical devices business based in the US. Insulet Corporation shares (PODD.US) are listed on the NASDAQ and all prices are listed in US dollars. Its last market close was $184.21 – a decrease of 6.56% over the previous day. Insulet Corporation employs 2,600 staff and has a trailing 12-month revenue of around $1.6 billion.

How to buy shares in Insulet Corporation

  1. Choose a platform. If you're a beginner, our stock trading platform picks below can help you choose.
  2. Open your account. Provide your personal information and sign up.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: PODD in this case.
  5. Research stocks. The platform should provide the latest information available.
  6. Buy your stocks. Place a market order or limit order with your preferred number of shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Best for Beginners

Go to site

  • Easy-to-use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award
Go to site

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Best for Easy-to-use App

Go to site

  • $50 in free trades
  • Low commissions
  • Easy-to-use app

Is it a good time to buy Insulet Corporation stock?

Only you can make the decision on the time to leap... but here's some supporting information and analysis.

Use our graph to track the performance of PODD stocks over time.

Share price volatility

Over the last 12 months, Insulet Corporation's shares have ranged in value from as little as $125.82 up to $335.91. A popular way to gauge a stock's volatility is its "beta".

PODD.US volatility(beta: 1.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Insulet Corporation's is 1.04. This would suggest that Insulet Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Historical closes compared with the last close of $184.21

1 week (2024-02-15)-3.56%
1 month (2024-01-25)-5.76%
3 months (2023-11-23)-1.99%
6 months (2023-08-24)0.66%
1 year (2023-02-23)-37.42%
2 years (2022-02-22)-20.19%
3 years (2021-02-25)-28.90%
5 years (2019-02-25)99.99%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Buy Insulet Corporation stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 4 of 4
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
Interactive Brokers
Finder Score:
★★★★★
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
$0
N/A
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
CASHBACK
CIBC Investor's Edge
Finder Score:
★★★★★
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$6.95
$0 if conditions met, or $100
100 free trades + up to $4,500 cash back
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Questrade
Finder Score:
★★★★★
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
$0
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
CASHBACK
Qtrade Direct Investing
Finder Score:
★★★★★
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $2,000 cashback as a new or existing client. Use promo code CASHBONUS2024. Ends March 4, 2024.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.
loading

Is Insulet Corporation under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Insulet Corporation P/E ratio, PEG ratio and EBITDA

Insulet Corporation's current stock price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 113x. In other words, Insulet Corporation stocks trade at around 113x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Insulet Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5679. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Insulet Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Insulet Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $157.7 million ($213 million CAD).

The EBITDA is a measure of a Insulet Corporation's overall financial performance and is widely used to measure a its profitability.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site